XML 59 R38.htm IDEA: XBRL DOCUMENT v3.23.3
Investment in Unconsolidated Ventures - Balance Sheet Information (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
ASSETS                
Real estate properties, net of accumulated depreciation of $67,399 and $66,945 $ 639,989     $ 651,603        
Cash and cash equivalents 28,117     20,281 $ 21,865      
Other assets 17,766     16,786        
Total Assets 721,142     732,118        
Liabilities:                
Mortgages payable, net of deferred costs of $1,185 and $1,421 422,935     403,792        
Accounts payable and accrued liabilities 24,272     22,631        
Total Liabilities 484,345     482,048        
Commitments and contingencies            
Equity:                
Total unconsolidated joint venture equity 236,797 $ 245,746 $ 243,334 250,070 $ 257,115 $ 249,150 $ 214,202 $ 202,951
Total Liabilities and Equity 721,142     732,118        
Deferred costs 4,486     4,941        
Unconsolidated Joint Ventures                
ASSETS                
Real estate properties, net of accumulated depreciation of $67,399 and $66,945 278,096     318,304        
Cash and cash equivalents 8,504     6,591        
Other assets 50,789     35,372        
Total Assets 337,389     360,267        
Liabilities:                
Mortgages payable, net of deferred costs of $1,185 and $1,421 242,763     255,261        
Accounts payable and accrued liabilities 11,547     8,222        
Total Liabilities 254,310     263,483        
Commitments and contingencies            
Equity:                
Total unconsolidated joint venture equity 83,079     96,784        
Total Liabilities and Equity 337,389     360,267        
BRT's interest in joint venture equity 34,501     42,576        
Unconsolidated Joint Ventures                
Equity:                
Real estate properties, net of accumulated depreciation 67,399     66,945        
Unconsolidated Joint Ventures | Mortgages payable                
Equity:                
Deferred costs $ 1,185     $ 1,421